These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trigger osteoclast formation and activation: molecular treatment strategy of delayed tooth eruption. Hua F; Zhang L; Chen Z Med Hypotheses; 2007; 69(6):1222-4. PubMed ID: 17560733 [TBL] [Abstract][Full Text] [Related]
4. New knowledge on the origin, function and fate of osteoclasts. Bonucci E Clin Orthop Relat Res; 1981; (158):252-69. PubMed ID: 6268344 [TBL] [Abstract][Full Text] [Related]
5. Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth. Qin H; Yang FS Med Hypotheses; 2008; 70(5):1048-50. PubMed ID: 18023993 [TBL] [Abstract][Full Text] [Related]
6. New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Crockett JC; Mellis DJ; Scott DI; Helfrich MH Osteoporos Int; 2011 Jan; 22(1):1-20. PubMed ID: 20458572 [TBL] [Abstract][Full Text] [Related]
7. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Everts V; de Vries TJ; Helfrich MH Biochim Biophys Acta; 2009 Aug; 1792(8):757-65. PubMed ID: 19465118 [TBL] [Abstract][Full Text] [Related]
8. Msx2 -/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis. Aïoub M; Lézot F; Molla M; Castaneda B; Robert B; Goubin G; Néfussi JR; Berdal A Bone; 2007 Nov; 41(5):851-9. PubMed ID: 17878071 [TBL] [Abstract][Full Text] [Related]
9. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498 [TBL] [Abstract][Full Text] [Related]
10. Delayed tooth eruption and suppressed osteoclast number in the eruption pathway of heterozygous Runx2/Cbfa1 knockout mice. Yoda S; Suda N; Kitahara Y; Komori T; Ohyama K Arch Oral Biol; 2004 Jun; 49(6):435-42. PubMed ID: 15099800 [TBL] [Abstract][Full Text] [Related]
11. Osteoclast biology: lessons from mammalian mutations. Marks SC Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780 [TBL] [Abstract][Full Text] [Related]
12. Osteopetrosis--multiple pathways for the interception of osteoclast function. Marks SC Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355 [TBL] [Abstract][Full Text] [Related]
13. Understanding bone cell biology requires an integrated approach: reliable opportunities to study osteoclast biology in vivo. Cielinski MJ; Marks SC J Cell Biochem; 1994 Nov; 56(3):315-22. PubMed ID: 7876324 [TBL] [Abstract][Full Text] [Related]
14. The cytology of the dental follicle and adjacent alveolar bone during tooth eruption in the dog. Marks SC; Cahill DR; Wise GE Am J Anat; 1983 Nov; 168(3):277-89. PubMed ID: 6650440 [TBL] [Abstract][Full Text] [Related]
15. Osteoclasts in human osteopetrosis contain viral-nucleocapsid-like nuclear inclusions. Mills BG; Yabe H; Singer FR J Bone Miner Res; 1988 Feb; 3(1):101-6. PubMed ID: 3213601 [TBL] [Abstract][Full Text] [Related]
16. Injections of osteoprotegerin and PMA delay tooth eruption. Wise GE; Yao S; Liu D Clin Anat; 2006 Jan; 19(1):19-24. PubMed ID: 16283633 [TBL] [Abstract][Full Text] [Related]
17. Effects of alendronate on tooth eruption and molar root formation in young growing rats. Bradaschia-Correa V; Massa LF; Arana-Chavez VE Cell Tissue Res; 2007 Dec; 330(3):475-85. PubMed ID: 17901984 [TBL] [Abstract][Full Text] [Related]
18. Reduction of osteoclasts in a critical embryonic period is essential for inhibition of mouse tooth eruption. Yoshino M; Yamazaki H; Yoshida H; Niida S; Nishikawa S; Ryoke K; Kunisada T; Hayashi S J Bone Miner Res; 2003 Jan; 18(1):108-16. PubMed ID: 12510811 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of alveolar bone during tooth eruption in the dog. Marks SC; Cahill DR Am J Anat; 1986 Nov; 177(3):427-38. PubMed ID: 3799493 [TBL] [Abstract][Full Text] [Related]
20. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]